Gattefossé mission, advancing science for well-being, reflects its core engagement: to provide expert, customized, and responsible solutions in Personal Care and Pharmaceuticals, including animal health.
Animal health at the core of Gattefossé business
As a long-established global supplier of lipid-based excipients for both human and veterinary medicines, Gattefossé partners with customers from the early stages of development through to market launch and throughout the entire product lifecycle.
With affiliates and distributors in over 90 countries, Gattefossé is always close to its customers, providing technical expertise and regulatory support. The four Technical Centers of Excellence – in China, France, India and the USA – play a crucial role in supporting the development of safe and efficient formulations for veterinary medicines.
Knowledge sharing is central to its daily operations. Through theoretical and hands-on training programs, conferences, webinars, and scientific publications, Gattefossé empowers professionals with the insights and expertise needed to develop innovative veterinary medicines. These efforts support all people involved in the animal health industry worldwide.
“At Gattefossé, we are dedicated to providing innovative drug delivery solutions that support the veterinary industry and enhance the animal health globally and locally. Our commitment to quality, safety, and sustainability ensures that we continue to meet the evolving needs of laboratories, veterinarians, care givers, and the broader healthcare ecosystem,” said Alexandre Gil, Pharmaceuticals Group Director.
Safe and efficient veterinary medicines
Recognizing the importance of the “One Health” approach, Gattefossé is committed to ensuring the safety of animals, the environment, and humans – including veterinarians, farmers, pet owners, and families.
Their CSR strategy, whose performance has been recognized with a gold medal from EcoVadis, further reinforces its commitment to sustainable and responsible practices in the veterinary pharmaceutical industry. At Gattefossé, the focus is on reducing carbon emissions, ensuring the sustainability of raw materials, and responsibly managing the natural resources they use. The company also works in close collaboration with academics and the animal health industry to help formulate sustainable veterinary medicines.
Their range of excipients consists of solvents, oils, co-surfactants, and surfactants, with diverse functionalities: dispersing agent, emulsifier, lubricant, oily vehicle, oral bioavailability enhancer, skin penetration enhancer, solubilizer, stabilizing agent, sustained release agent, taste-masking agent, etc. Gattefossé’s multi-functional excipients meet the highest quality and safety standards, offering solutions for all species, regardless of the route of administration or dosage form.
Some examples for skin delivery include spot-ons, pour-ons, and intramammary suspensions. For oral products, soft chews, tablets, oral pastes, and drinking water medications are formulated with lipid excipients. In injectable products, safe solvents and solubilizers are used in solutions or suspensions. With a proven track record in veterinary medicine, these excipients are used in formulations for both companion and food-producing animals.
“We provide strong support to our customers and partners worldwide in developing veterinary medicines that better meet market demands. By improving bioavailability with lipid-based formulations we enhance the efficacy of veterinary medicines. Additionally, by increasing compliance with long-acting dosage forms and facilitating administration through user-friendly dosage forms, we aim to improve the daily lives of those involved in animal health”, said Cécile Morin, Veterinary Program Manager.
To learn more, read the brochure or visit the website.
